| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 02/19/2015 | US20150050353 Film-coated and/or granulated calcium-containing compounds and use therof in pharmaceutical compositions |
| 02/19/2015 | US20150050352 Enteric Coated Multiparticulate Composition With Proteinaceous Subcoat |
| 02/19/2015 | US20150050350 Pharmaceutical formulations for dry powder inhalers |
| 02/19/2015 | US20150050349 Systems and methods for particle radiation enhanced delivery of therapy |
| 02/19/2015 | US20150050348 Biomechanical force mitigation in the delivery of stem cell therapies |
| 02/19/2015 | US20150050347 Reverse micelle system comprising nucleic acids and use thereof |
| 02/19/2015 | US20150050346 Compositions and methods for treating insulin resistance and diabetes mellitus |
| 02/19/2015 | US20150050345 Methods for fine particle manufacture |
| 02/19/2015 | US20150050344 Compositions and methods for upregulating hippocampal plasticity and hippocampus-dependent learning and memory |
| 02/19/2015 | US20150050343 Methods of wound care and treatment |
| 02/19/2015 | US20150050342 Compositions for treatment of skin disorders |
| 02/19/2015 | US20150050340 Sustained-release drug carrier composition |
| 02/19/2015 | US20150050338 Method for treatment of diarrhea-predominant irritable bowel syndrome |
| 02/19/2015 | US20150050337 Extended Release Compositions |
| 02/19/2015 | US20150050336 Taste Masking System For Non-Plasticizing Drugs |
| 02/19/2015 | US20150050335 Extended Release Pharmaceutical Formulations of Water-Soluble Active Pharmaceutical Ingredients and Methods for Making the Same |
| 02/19/2015 | US20150050334 Acid resistant capsules |
| 02/19/2015 | US20150050333 Pharmaceutical composition comprising olmesartan medoxomil and rosuvastatin or its salt |
| 02/19/2015 | US20150050331 Method for making a topical composition comprising growth factors derived from human umbilical cord blood platelets |
| 02/19/2015 | US20150050330 Compositions and methods for polymer-caged liposomes |
| 02/19/2015 | US20150050329 Liposomal corticosteroids for treatment of inflammatory disorders in humans |
| 02/19/2015 | US20150050327 Liposome formulation suitable for treating or preventing tuberculosis |
| 02/19/2015 | US20150050323 Biomass hetero-colloidal systems, production and uses thereof |
| 02/19/2015 | US20150050318 Multivalent nanoemulsion vaccines |
| 02/19/2015 | US20150050245 Methods and delivery system for beneficial additive and subtractive biological agents to promote balanced mammalian gastrointestinal flora |
| 02/19/2015 | US20150050221 Compositions and Methods for the Maintenance of Oral Health |
| 02/19/2015 | US20150050219 Coloured solution in particular for use in surgical methods for the treatment of the bodies of humans or animals |
| 02/19/2015 | US20150050217 Ultrafine nanoparticles as multimodal contrast agent |
| 02/19/2015 | US20150050210 Pharmaceutical formulation comprising bendamustine |
| 02/19/2015 | DE112013002492T5 Vesikuläre Formulierungen, Verwendungen und Verfahren Vesicular formulations, uses and methods |
| 02/19/2015 | DE102013218239A1 Verfahren zur Herstellung eines Produktes mittels Dialyse A method for producing a product by dialysis |
| 02/18/2015 | EP2837392A2 Modified erythropoietin to which water-soluble long-chain molecule is added |
| 02/18/2015 | EP2837391A1 Hypromellose acetate succinate for use as hot-melt extrusion carrier, hot-melt extrusion composition, and method for producing hot-melt extrudate |
| 02/18/2015 | EP2837389A1 Medicinal composition for treating infarction |
| 02/18/2015 | EP2837384A1 Glutathione based delivery system |
| 02/18/2015 | EP2837380A1 Lercanidipine hydrochloride and losartan potassium compound preparation and preparation method thereof |
| 02/18/2015 | EP2837379A1 Dosage form comprising a 5-alpha-reductase steroid inhibitor and an alpha blocker, process for the preparation of a dosage form, use of dosage form, method for the treatment or prophylaxis of a disease or condition mediated by androgen |
| 02/18/2015 | EP2837378A1 Pharmaceutical compositions of rifaximin |
| 02/18/2015 | EP2837377A1 Lyophilization of synthetic liposomal pulmonary surfactant |
| 02/18/2015 | EP2837376A2 Compacted moxifloxacin |
| 02/18/2015 | EP2836559A1 Composition comprising an organic diluent and a cellulose ether |
| 02/18/2015 | EP2836517A1 Melt-extruded composition comprising a cellulose ether |
| 02/18/2015 | EP2836236A1 Methods and compositions for preparing a silk microsphere |
| 02/18/2015 | EP2836235A1 Novel sustained release dosage forms |
| 02/18/2015 | EP2836234A1 Vehicles for controlled delivery of different pharmaceutical agents |
| 02/18/2015 | EP2836233A1 Sustained-release formulation |
| 02/18/2015 | EP2836229A1 Liposomes containing oligopeptide fragments of myelin basic protein, a pharmaceutical composition and a method for treatment of multiple sclerosis |
| 02/18/2015 | EP2836207A1 Composite formulation comprising multi-unit spheroidal tablet (must) encapsulated in hard capsule and method for preparing same |
| 02/18/2015 | EP2836206A2 Controlled release pharmaceutical formulations of direct thrombin inhibitors |
| 02/18/2015 | EP2836205A1 Esterified cellulose ethers having a specific substituent distribution |
| 02/18/2015 | EP2836204A1 Aggregate particles |
| 02/18/2015 | EP2836203A1 Vesicular formulations for use in the treatment of pain or reduced mobility of a joint |
| 02/18/2015 | EP2836202A1 Pharmaceutical composition containing an unsaturated fatty acid enriched with oxygen and an organic solvent |
| 02/18/2015 | EP2836201A1 Modified release liquid pharmaceutical composition comprising bromopheniramine, pseudoephedrine and dextromethorphan |
| 02/18/2015 | EP2836200A2 Reverse thermal hydrogel preparations for use in the treatment of disorders of the urothelium |
| 02/18/2015 | EP2836199A1 Fulvestrant formulations |
| 02/18/2015 | EP2836198A2 Pharmaceutical composition comprising arformoterol and fluticasone furoate |
| 02/18/2015 | EP2836197A1 Oral film containing opiate enteric-release beads |
| 02/18/2015 | EP2836196A1 Preparation for topical application to mucosa containing polyhexanide as active ingredient |
| 02/18/2015 | EP2836195A1 System and method for multiphasic release of growth factors |
| 02/18/2015 | EP2836172A1 Hollow drug-filled stent and method of forming hollow drug-filled stent |
| 02/18/2015 | EP2836071A1 Composition for the treatment of pediculosis and corresponding manufacturing process |
| 02/17/2015 | US8957202 Enterosoluble and intestinal-enzyme-biodegradable materials and method for preparing the same |
| 02/17/2015 | US8957198 Compositions, devices and methods for treatment of Huntington's disease through intracranial delivery of sirna |
| 02/17/2015 | US8957115 Pheromone compositions and methods of use |
| 02/17/2015 | US8957114 Formulations, salts and polymorphs of transnorsertraline and uses thereof |
| 02/17/2015 | US8957113 Tranexamic acid formulations |
| 02/17/2015 | US8957110 Ophthalmic compositions based on polyunsaturated omega-3 and omega-6 fatty acids |
| 02/17/2015 | US8957080 Tyrosine kinase inhibitors |
| 02/17/2015 | US8957079 Inhibitors of Bruton's tyrosine kinase |
| 02/17/2015 | US8957076 Wound healing |
| 02/17/2015 | US8957062 Substituted cyclopropyl compounds, compositions containing such compounds and methods of treatment |
| 02/17/2015 | US8957054 Pharmaceutical compositions |
| 02/17/2015 | US8957053 Proliposomal testosterone formulations |
| 02/17/2015 | US8957048 Compositions for the treatment of dry eye |
| 02/17/2015 | US8957034 Drugs and gene carrier particles that rapidly move through mucous barriers |
| 02/17/2015 | US8957033 Inhibitor of sodium-dependent glucose transport protein and preparation method therefor and use thereof |
| 02/17/2015 | US8957001 Particles comprising a biopolymer which is degradable under the effect of an electromagnetic wave as emitted by a solar radiation |
| 02/17/2015 | US8956685 Use of dams to improve yield in film processing |
| 02/17/2015 | US8956682 Hydrophilic polymeric coatings for medical articles with visualization moiety |
| 02/17/2015 | US8956662 Phenylephrine pharmaceutical formulations and compositions for colonic absorption |
| 02/17/2015 | US8956661 Method of making composite particles for use in pharmaceutical compositions and composite particles and compositions thereof |
| 02/17/2015 | US8956660 Production of nanoparticles, especially nanoparticle composites, from powder agglomerates |
| 02/17/2015 | US8956659 Fulvestrant nanosphere/microsphere and preparative method and use thereof |
| 02/17/2015 | US8956658 Nitric oxide-releasing particles for nitric oxide therapeutics and biomedical applications |
| 02/17/2015 | US8956657 Stable formulations for lyophilizing therapeutic particles |
| 02/17/2015 | US8956656 Production of small particles |
| 02/17/2015 | US8956654 Sustained release dosage form |
| 02/17/2015 | US8956653 Preparations for effervescent formulations comprising cephalosporin and uses thereof |
| 02/17/2015 | US8956652 Effervescent rehydrating beverage tablet/granules |
| 02/17/2015 | US8956651 Oral formulations and lipophilic salts of methylnal trexone |
| 02/17/2015 | US8956650 Intrabuccally rapidly disintegrating tablet and a production method of the tablets |
| 02/17/2015 | US8956649 Orally effective methylphenidate extended release powder and aqueous suspension product |
| 02/17/2015 | US8956648 Calciumphosphate-based nanoparticles as carrier-systems for photodynamic therapy |
| 02/17/2015 | US8956647 Pellet formulation for the treatment of the intestinal tract |
| 02/17/2015 | US8956646 Zwitterionic lipids |
| 02/17/2015 | US8956645 Water-soluble pharmaceutical composition comprising at least one therapeutically active substance having hydrophobic properties and at least one compound selected from among sialoglycosphingolipids, glycosphingolipids or a mixture of sialoglycosphingolipids and glycosphingolipids |
| 02/17/2015 | US8956644 Transdermal delivery systems |
| 02/17/2015 | US8956641 Alpha adrenergic receptor agonists for treatment of inflammatory diseases |
| 02/17/2015 | US8956636 Methods and compositions for treating postoperative pain comprosing ketorolac |